Dent R, Oliveira M, Isakoff SJ, Im SA, et al. Final results of the double-blind placebo-controlled randomized phase 2 LOTUS
trial of first-line ipatasertib plus paclitaxel for inoperable locally
advanced/metastatic triple-negative breast cancer. Breast Cancer Res Treat 2021 Jul 15. pii: 10.1007/s10549-021-06143.
PMID: 34264439